NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immunovant, Inc. ("Immunovant" or the "Business") (NASDAQ:...
Immunovant
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immunovant, Inc. ("Immunovant" or the "Business") (NASDAQ:...
